Hederasaponin C can inhibit the activation of NF-κB and NLRP3 inflammasome by inhibiting the binding of TAK1 and PIP2 in macrophages induced by LPS, thus inhibiting ALI induced by LPS [91]. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.